enVVeno Medical (NVNO) Competitors $0.93 0.00 (-0.16%) Closing price 04:00 PM EasternExtended Trading$0.92 -0.02 (-1.85%) As of 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVNO vs. QTI, LUNG, TELA, SURG, CTSO, DXR, PYPD, MDAI, SRTS, and APTShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include QT Imaging (QTI), Pulmonx (LUNG), TELA Bio (TELA), SurgePays (SURG), Cytosorbents (CTSO), Daxor (DXR), PolyPid (PYPD), Spectral AI (MDAI), Sensus Healthcare (SRTS), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry. enVVeno Medical vs. Its Competitors QT Imaging Pulmonx TELA Bio SurgePays Cytosorbents Daxor PolyPid Spectral AI Sensus Healthcare Alpha Pro Tech QT Imaging (NASDAQ:QTI) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Do institutionals & insiders have more ownership in QTI or NVNO? 24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by insiders. Comparatively, 16.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor QTI or NVNO? In the previous week, enVVeno Medical had 2 more articles in the media than QT Imaging. MarketBeat recorded 2 mentions for enVVeno Medical and 0 mentions for QT Imaging. QT Imaging's average media sentiment score of 0.00 beat enVVeno Medical's score of -0.33 indicating that QT Imaging is being referred to more favorably in the media. Company Overall Sentiment QT Imaging Neutral enVVeno Medical Neutral Do analysts rate QTI or NVNO? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00enVVeno Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, QTI or NVNO? QT Imaging has a beta of -0.2, indicating that its share price is 120% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Which has stronger earnings & valuation, QTI or NVNO? QT Imaging has higher revenue and earnings than enVVeno Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQT Imaging$4.00M16.77-$4.03MN/AN/AenVVeno MedicalN/AN/A-$21.82M-$1.20-0.78 Is QTI or NVNO more profitable? QT Imaging's return on equity of 0.00% beat enVVeno Medical's return on equity.Company Net Margins Return on Equity Return on Assets QT ImagingN/A N/A -65.94% enVVeno Medical N/A -57.35%-53.49% SummaryQT Imaging and enVVeno Medical tied by winning 5 of the 10 factors compared between the two stocks. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.96M$6.69B$5.76B$10.42BDividend YieldN/A1.20%5.74%4.63%P/E Ratio-0.7826.7876.5526.74Price / SalesN/A196.80495.39162.18Price / CashN/A21.6337.1760.63Price / Book0.394.9813.726.40Net Income-$21.82M$178.07M$3.29B$271.71M7 Day Performance19.44%5.36%1.03%2.85%1 Month Performance-77.73%9.65%6.32%9.64%1 Year Performance-81.74%18.22%81.16%31.62% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical0.6079 of 5 stars$0.93-0.2%N/A-81.7%$17.96MN/A-0.7830QTIQT ImagingN/A$2.48-2.7%N/A+317.2%$67.29M$4.00M0.00N/ALUNGPulmonx3.5705 of 5 stars$1.58-0.6%$7.66+385.1%-81.0%$64.79M$83.79M0.00250Positive NewsTELATELA Bio2.4823 of 5 stars$1.58flat$4.50+184.8%-40.9%$62.59M$69.30M0.00120SURGSurgePays2.9883 of 5 stars$2.99-2.0%$9.00+201.0%+73.5%$62.32M$60.88M-1.2040High Trading VolumeCTSOCytosorbents2.4366 of 5 stars$0.91-0.7%$5.50+505.0%-34.3%$57.45M$35.60M-5.35220Analyst ForecastDXRDaxor4.0365 of 5 stars$11.43-1.8%$25.00+118.7%+23.1%$56.30MN/A0.0037Positive NewsShort Interest ↓PYPDPolyPid3.312 of 5 stars$3.43+1.2%$12.40+261.5%+1.4%$53.89MN/A0.0080Short Interest ↓MDAISpectral AI2.3962 of 5 stars$2.06+3.5%$3.50+69.9%+88.9%$53.19M$29.58M0.0083News CoverageGap UpSRTSSensus Healthcare2.7395 of 5 stars$3.15flat$8.00+154.0%-48.3%$51.79M$41.81M-52.5040APTAlpha Pro Tech2.7089 of 5 stars$4.86+0.3%N/A-13.6%$50.85M$58.56M13.12120Positive News Related Companies and Tools Related Companies QTI Alternatives LUNG Alternatives TELA Alternatives SURG Alternatives CTSO Alternatives DXR Alternatives PYPD Alternatives MDAI Alternatives SRTS Alternatives APT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVNO) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVNO Stock Alerts